top of page
Antibody_scene_3a.webp

Partnering
to strengthen biologics pipelines

Collaborative problem-solving at the intersection of drug development and AI.

OVERVIEW

Solving complex drug development challenges together

At Etcembly, partnerships begin with a problem. Whether it’s a novel biological question or a unique development hurdle, we collaborate closely to help your team explore more ideas, test them faster, and build better therapeutics at the speed of imagination.

THE OPPORTUNITY

Why partner with Etcembly

Custom solutions

Every partnership is built around a specific scientific or strategic need. We don’t apply generic tools to complex problems. We design tailored solutions grounded in your unique challenges and objectives.

AI+drug development expertise

Our team operates at the intersection of computational innovation and translational science. That dual perspective allows us to deliver solutions that are not only technically sophisticated but biologically meaningful.

Collaborative by design

Our partnerships are built on responsiveness and shared ambition. We work closely with you to align on goals, define success metrics, and iterate rapidly.

PARTNERSHIP HIGHLIGHTS
EtcemblyPartnerLogo_Zelluna.png

This collaboration combined Etcembly’s AI-driven antibody optimisation capabilities with Zelluna’s pioneering work in cell therapy to support the development of ZI-MA4-1, a T-cell receptor natural killer (TCR-NK) therapy targeting solid tumours. ZI-MA4-1

 

Explore the progress of ZI-MA4-1 toward first-in-human trials →

EtcemblyPartnerLogo_VectorLabs.png

See how Etcembly leveraged its deep understanding of key manufacturability issues to help Vector Labs design better antibody variants.

EtcemblyPartnerLogo_Twist.png

Learn how Etcembly helped Twist Biosciences improve the expression yields of antibody candidates.

WORK WITH US

Bring us your challenge

If your organization is tackling a complex drug development problem and seeking a strategic AI partner, we would welcome the opportunity to discuss.

bottom of page